On Giving Tuesday, please consider supporting Retraction Watch

We know there are a lot of causes that matter to you, but since you’re reading this, we may be one of them. So we’d like to ask for your support.

On this Giving Tuesday, please consider making a tax-deductible contribution to The Center For Scientific Integrity, the 501(c)3 parent organization of Retraction Watch. Any amount helps. Your donation will help us shine a spotlight on scientific misconduct, and hold accountable the entities that profit from publishing, including journals, institutions, and individuals.

Here’s what your donations will continue to help make possible:

Continue reading On Giving Tuesday, please consider supporting Retraction Watch

Dental researcher in Spain up to 18 retractions

Jose Luis Calvo-Guirado

A researcher in Spain who studies dental implants has had another six papers retracted, for a total of 18.

José Luis Calvo-Guirado‘s latest retraction, which along with the other 17 appeared in Clinical Oral Implants Research, a Wiley title, was for “image discrepancies resulting in unreliable data.” Three appeared in June, and two in July, also for image issues. The researcher also has at least two corrections; one  in Annals of Anatomy — Anatomischer Anzeiger and one in Materials. Continue reading Dental researcher in Spain up to 18 retractions

Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured some big numbers: 26 retractions for an engineer in Italy, all at once; 15 expressions of concern for Piero Anversa’s cardiac stem cell research; three retractions and 10 corrections for a researcher in South Korea; and also the retraction of a paper on ketamine for bipolar depression. Here’s what was happening elsewhere: Continue reading Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors

Legal threats, opacity, and deceptive research practices: A look at more than 100 retractions in business and management

Dennis Tourish

What can studying retractions in business and management journals tell us? Earlier this year, Dennis Tourish, of the University of Sussex, and Russell Craig, of the University of Portsmouth, both in the UK, published a paper in the Journal of Management Inquiry that analyzed 131 such retractions. The duo — who were also two of three authors of a recent paper on retractions in economics — also interviewed three journal editors involved in retractions, two co-authors of retracted papers who were not responsible for the fraud, and one researcher found to have committed fraud. We asked Tourish, the author of an upcoming book on “fraud, deception and meaningless research” in management studies, some questions about the study by email.

Retraction Watch (RW): You found a “large proportion of retractions in high-quality journals.” Would you say that is consistent with findings in other fields? Continue reading Legal threats, opacity, and deceptive research practices: A look at more than 100 retractions in business and management

Engineering prof in Italy earns 26 retractions in one fell swoop

Antonio Orlandi

Antonio Orlandi, a professor of electrical engineering at the University of L’Aquila, in Italy, has had 26 papers retracted from a single journal, on a single day.

Orlandi’s retractions come with a twist: He was, until recently, the editor in chief of the journal where the articles appeared, IEEE Transactions on Electromagnetic Compatibility. Continue reading Engineering prof in Italy earns 26 retractions in one fell swoop

Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

Piero Anversa

More than four and a half years after questions were first raised about work in a cardiac stem cell lab at Harvard and the Brigham and Women’s Hospital, a year and a half after the Brigham and Partners Healthcare paid $10 million to settle allegations of fraud in the lab’s data, a month after Harvard the Brigham disclosed that they were calling for the retractions of more than 30 papers from the lab, and three weeks after the NIH paused a clinical trial based on the work, two leading journals have issued an expression of concern about 15 papers from the lab.

But expressions of concern are not retractions, of course. From the notice, in Circulation and Circulation Research, both of which are published by the American Heart Association: Continue reading Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

Tech society retracts 29 articles, ousts three editors for “systematic violation” of peer review policies

The Institute of Electrical and Electronics Engineers (IEEE), a scientific society that doubles as one of the world’s largest scientific publishers, is retracting nearly 30 articles from a single journal after finding “evidence of systematic violation of IEEE’s policies governing peer review of articles.”

In a statement, IEEE said: Continue reading Tech society retracts 29 articles, ousts three editors for “systematic violation” of peer review policies

Researcher in South Korea racks up three retractions and at least 10 corrections

Joohun Ha

A professor at Kyung-Hee University in Seoul, South Korea, has retracted three articles and had at least ten corrected, all for image manipulation, duplication, or errors.

Joohun Ha’s three retractions all appeared in the Journal of Biological Chemistry (JBC). One of the papers, “AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells,” first published in 2003, has been cited 186 times, according to Clarivate Analytics’ Web of Science. Here’s the retraction notice: Continue reading Researcher in South Korea racks up three retractions and at least 10 corrections

Ketamine for depression? Paper retracted for error that double-counted clinical trial participants

A psychiatry journal has retracted a 2015 meta-analysis on the effectiveness of ketamine for depression after readers found that the article double-counted patients in some studies, thereby inflating the apparent benefits of the drug.

The article, “Efficacy of ketamine in bipolar depression: systematic review and meta-analysis,” was published in the Journal of Psychiatric Practice by a group from the United States and England. But a pair of researchers in Sweden noticed the duplication — and what seems to have been a rather slapdash approach to the work — and pushed to have the paper retracted.

According to the results section of the abstract: Continue reading Ketamine for depression? Paper retracted for error that double-counted clinical trial participants

Weekend reads: A climate change study correction; predatory journal critic banned from campus; why are publishers “the joint enemy?”

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured the tale of the researcher who pleaded guilty to faking data and then published a paper on diet, the scientist who plagiarized a Harvard grant application, and the first-ever retraction from the U.S. CDC’s flagship journal. Here’s what was happening elsewhere: Continue reading Weekend reads: A climate change study correction; predatory journal critic banned from campus; why are publishers “the joint enemy?”